HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of angiotensin conversion in experimental renovascular hypertension.

Abstract
Constriction of the renal artery and controlled reduction of renal perfusion pressure is followed by a prompt increase in systemic renin activity and a concomitant rise in blood pressure in trained, unanesthetized dogs. The elevated blood pressure induced by the renal artery stenosis can be prevented by prior treatment with the nonapeptide Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro, which blocks conversion of angiotensin I to angiotensin II. Further, the nonapeptide can restore systemic pressure to normnal in the early phase of renovascular hypertension. These results offer strong evidence that the renin-angiotensin system is responsible for the initiation of hypertension in the unilaterally nephrectomized dog with renal artery constriction.
AuthorsE D Miller Jr, A I Samuels, E Haber, A C Barger
JournalScience (New York, N.Y.) (Science) Vol. 177 Issue 4054 Pg. 1108-9 (Sep 22 1972) ISSN: 0036-8075 [Print] United States
PMID4341125 (Publication Type: Journal Article)
Chemical References
  • Peptides
  • Venoms
  • Angiotensin II
  • Renin
  • Bradykinin
Topics
  • Angiotensin II (metabolism)
  • Animals
  • Blood Pressure (drug effects)
  • Bradykinin (blood)
  • Dogs
  • Hypertension, Renal (metabolism)
  • Injections, Intravenous
  • Male
  • Peptides (administration & dosage, isolation & purification, pharmacology)
  • Renin (blood)
  • Venoms (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: